148 related articles for article (PubMed ID: 8773112)
1. Xanthelasma palpebrum--a marker for hyperlipidemia in NIDDM patients?
Premalatha G; Mohan V
J Assoc Physicians India; 1996 Jan; 44(1):73-4. PubMed ID: 8773112
[No Abstract] [Full Text] [Related]
2. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a).
Ozdöl S; Sahin S; Tokgözoğlu L
Int J Dermatol; 2008 Aug; 47(8):785-9. PubMed ID: 18717856
[TBL] [Abstract][Full Text] [Related]
3. An Updated Work-Up for Patients With Xanthelasma Palpebrarum.
Rothstein BE; Cohen JL
Dermatol Surg; 2021 Aug; 47(8):1170-1171. PubMed ID: 33988552
[No Abstract] [Full Text] [Related]
4. C-reactive protein in diabetes mellitus and hyperlipidemia.
Khoja SM; Alabbassi FA; Abuelgassim AO; Al-Bar OA
Saudi Med J; 2004 Jan; 25(1):119-21. PubMed ID: 14758399
[No Abstract] [Full Text] [Related]
5. Case: asymptomatic lesions on eyelids.
Levine N
Geriatrics; 2008 Aug; 63(8):31. PubMed ID: 18672954
[No Abstract] [Full Text] [Related]
6. [Clinical significance of small, dense LDL cholesterol in patients with hyperlipidemia and type 2 diabetes].
Shishino K; Ochi M; Murase M; Osawa H; Makino H
Rinsho Byori; 2007 Aug; 55(8):705-11. PubMed ID: 17882792
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of plasma lipids and clinical characteristics of patients with xanthelasma palpebrarum (author's transl)].
Zeman M; Zák A; Herdová J
Cas Lek Cesk; 1981 Jul; 120(26):806-8. PubMed ID: 7261000
[No Abstract] [Full Text] [Related]
8. [Hypolipidemic effects of alisat and lipostabil in patients with diabetes mellitus].
Mel'chinskaia EN; Gromnatskiĭ NI; Kirichenko LL
Ter Arkh; 2000; 72(8):57-8. PubMed ID: 11019431
[TBL] [Abstract][Full Text] [Related]
9. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients.
Seyoum B; Abdulkadir J; Berhanu P; Feleke Y; Mengistu Z; Worku Y; Ayana G
Ethiop Med J; 2003 Jan; 41(1):1-8. PubMed ID: 12764995
[TBL] [Abstract][Full Text] [Related]
10. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
Wolffenbuttel BH; Huijberts MS
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):761-5. PubMed ID: 11346911
[TBL] [Abstract][Full Text] [Related]
11. [Dyslipidemia in diabetes mellitus].
Niemeijer-Kanters SD; Banga JD; Erkelens DW
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
[TBL] [Abstract][Full Text] [Related]
12. Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum.
Kavoussi H; Ebrahimi A; Rezaei M; Ramezani M; Najafi B; Kavoussi R
An Bras Dermatol; 2016; 91(4):468-71. PubMed ID: 27579742
[TBL] [Abstract][Full Text] [Related]
13. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).
Uddin F; Miah AK
Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864
[TBL] [Abstract][Full Text] [Related]
14. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia.
Ristić Medić D; Ristić V; Arsić A; Postić M; Ristić G; Blazencić Mladenović V; Tepsić J
Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):395-404. PubMed ID: 16935698
[TBL] [Abstract][Full Text] [Related]
15. Xanthelasma is not associated with increased risk of carotid atherosclerosis in normolipidaemia.
Chan CC; Lin SJ; Hwang JJ; Sun CC; Jeng JS; Hwang BS; Chiu HC; Chen MF; Liau CS; Hsu HJ; Su TC
Int J Clin Pract; 2008 Feb; 62(2):221-7. PubMed ID: 18036167
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus.
Matsumoto K; Fujita N; Nakamura K; Senoo T; Tominaga T; Ueki Y
Diabetes Res Clin Pract; 2008 Oct; 82(1):93-7. PubMed ID: 18684539
[TBL] [Abstract][Full Text] [Related]
17. Coronary risk and dyslipidemia in type 2 diabetic patients.
Udawat H; Goyal RK; Maheshwari S
J Assoc Physicians India; 2001 Oct; 49():970-3. PubMed ID: 11848328
[TBL] [Abstract][Full Text] [Related]
18. [Effect of probucol on cardiac electrophysiology in anginal patients with hyperlipidemia and diabetes mellitus type II].
Anikin VV; Savin VV; Lupanov VP; Razygraev RA
Ter Arkh; 2000; 72(8):28-30. PubMed ID: 11019422
[TBL] [Abstract][Full Text] [Related]
19. [Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].
Broedl UC; Lehrke M; Parhofer KG
MMW Fortschr Med; 2008 Jun; 150(25):41-3. PubMed ID: 18705054
[No Abstract] [Full Text] [Related]
20. [Xanthelasma palpebrarum and dyslipoproteinaemia: two retrospective studies (author's transl)].
Rouffy J; Chanu B; Bakir R; Goy-Loeper J; Bouthillier D; Goussault Y; Dreux C
Ann Dermatol Venereol; 1982; 109(3):231-5. PubMed ID: 7114736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
